Vericel Corporation (VCEL)

50.33 -1.20 (-2.33%) 收市：04:00PM EDT

Vericel Corporation

64 Sidney Street
Cambridge, MA 02139
United States
617 588 5555
https://vcel.com

版塊: Healthcare
行業: Biotechnology
全職員工: 314

高階主管

名稱	頭銜	支付	行使價	出生年份
Mr. Dominick C. Colangelo Esq.	CEO, President & Director	1.54M	1.51M	1964
Mr. Joseph Anthony Mara Jr.	CFO & Treasurer	750.61k	無	1976
Mr. Michael Halpin	Chief Operating Officer	796.91k	492.26k	1962
Mr. Sean C. Flynn	Chief Legal Officer	657.01k	無	1974
Dr. Jonathan M. Hopper FRCSEd., M.B. Ch.B.	Chief Medical Officer	672.16k	127.25k	1962
Mr. Jonathan D. Siegal	Principal Accounting Officer, VP & Corporate Controller	無	無	無
Mr. Eric Burns	Vice President of Finance & Investor Relations	無	無	無
Mr. Patrick J. Fowler	Senior Vice President of Corporate Development & Strategy	無	無	無
Mr. Patrick Helfrich	Vice President of Marketing & Commercial Strategy	無	無	無
Mr. Mike Gilligan	Senior Vice President of Sales	無	無	無

截止 2023年12月31日為止計算的金額，現金賠償則計算至上一個財政年度末止。薪資是指薪俸、獎金等。已行使價是指財政年度期間已行使的期權價值。貨幣為 USD。

描述

Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in North America. The company markets autologous cell therapy products comprising MACI, an autologous cultured chondrocytes on porcine collagen membrane for the repair of symptomatic, and single or multiple full-thickness cartilage defects of the knee; Epicel, a permanent skin replacement humanitarian use device for the treatment of adult and pediatric patients with deep-dermal or full-thickness burns; and NexoBrid, a biological orphan product for eschar removal in adults with deep partial-thickness and/or full-thickness thermal burns. The company was formerly known as Aastrom Biosciences, Inc. Vericel Corporation was incorporated in 1989 and is headquartered in Cambridge, Massachusetts.

公司管治

截至 2024年5月1日 止，Vericel Corporation 的 ISS 管治質素評分為 4。 Pillar 分數正在審核中：6；董事會：3；股東權利：4；現金賠償：6。

企業管治評分的資料提供： Institutional Shareholder Services (ISS). 評分將以 1 至 10 分顯示 (與指數或地區相關)。1 分表示較低的管治風險，而 10 分表示較高的管治風險。